ARID5B and acute lymphoblastic leukemia: To understand the underlying mechanism of ARID5B low expression in ALL, we studied Ikaros binding sites present in the ARID5B promoter region by ChIP-seq assay, in Nalm6 (Fig. 2a) and primary B-ALL cells (Fig S5)13,14.